Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Oracea NDA submission accepted for review

Oct. 5, 2005

A novel bimosiamose formulation reduces plaque thickness in psoriasis

Oct. 5, 2005

Pimecrolimus reported effective in facial seborrheic dermatitis

Oct. 5, 2005

Novel agents for dermatological disorders emerge from pharma R&D

Oct. 4, 2005

CNTO-1275 shows promise in moderate to severe psoriasis

Oct. 4, 2005

Adhibit prevents formation of surgical adhesions after myomectomy

Oct. 4, 2005

Therapeutic benefits of NSC-631570 in xeroderma pigmentosum

Oct. 3, 2005

UR-1505 modulates T cell proliferation and cytokine production

Sep. 29, 2005

CollaGenex studies incyclinide for acne

Sep. 28, 2005

Topical BAL-10092 reduces skin inflammation in preclinical and human models

Sep. 27, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...